TipRanks on MSN

Lupin Launches First PrecisionSphere™ Product in U.S. with Risperidone Injectable

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Limited has launched Risperidone for extended-release injectable suspension in the ...
Hosted on MSN

Dementia drug raises stroke risk—even in 'low-risk' patients, study shows

A major U.K. study of more than 165,000 dementia patients has found that risperidone raises stroke risk without exception, challenging safety assumptions by leaving no "safe group." Subscribe to our ...
Medscape

Acute Phase Dose Risperidone More Effective at Relapse Prevention in Maintenance Schizophrenia Than Reduced Dose Strategies

March 24, 2010 — One year of maintenance risperidone administered at the initial therapeutic dose for acute schizophrenia is more effective at preventing relapse than dose reduction strategies and is ...
Medical Dialogues

Lupin unveils Risperidone Long Acting Injectable in US

Mumbai: Global pharma major Lupin Limited has announced the launch of Risperidone for extended-release injectable suspension, ...
Nasdaq

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from ...

--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., today presented data informing clinical strategies for switching patients to UZEDY ®, an extended-release injectable ...
Nasdaq

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients ...

PARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)-- Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell ...
Medscape

Risperidone Versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder

Patients. A total of 675 patients were involved in the ITT analysis (risperidone group, n = 349; conventional antipsychotic group, n = 326). The baseline demographics and the clinical characteristics ...